Diagnostic Use ofIDH1/2Mutation Analysis in Routine Clinical Testing of Formalin-Fixed, Paraffin-Embedded Glioma Tissues
Open Access
- 1 December 2009
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Neuropathology and Experimental Neurology
- Vol. 68 (12) , 1319-1325
- https://doi.org/10.1097/nen.0b013e3181c391be
Abstract
Mutations in isocitrate dehydrogenase enzyme isoforms 1 (IDH1) and 2 (IDH2) have been identified in many adult astrocytomas and oligodendrogliomas. TKeywords
This publication has 14 references indexed in Scilit:
- Isocitrate Dehydrogenase 1 Codon 132 Mutation Is an Important Prognostic Biomarker in GliomasJournal of Clinical Oncology, 2009
- Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomasActa Neuropathologica, 2009
- Chordoid Glioma: A Case Report and Molecular Characterization of Five CasesBrain Pathology, 2009
- Glioma-Derived Mutations in IDH1 Dominantly Inhibit IDH1 Catalytic Activity and Induce HIF-1αScience, 2009
- Mutational analysis of IDH1 codon 132 in glioblastomas and other common cancersInternational Journal of Cancer, 2009
- IDH1andIDH2Mutations in GliomasNew England Journal of Medicine, 2009
- Metabolic Enzymes as Oncogenes or Tumor SuppressorsNew England Journal of Medicine, 2009
- IDH1mutations at residue p.R132 (IDH1R132) occur frequently in high-grade gliomas but not in other solid tumorsHuman Mutation, 2008
- Analysis of the IDH1 codon 132 mutation in brain tumorsActa Neuropathologica, 2008
- An Integrated Genomic Analysis of Human Glioblastoma MultiformeScience, 2008